Comparison of Efficacy of Aripiprazole versus Risperidone Augmentation of Selective Serotonin Reuptake Inhibitors for Treatment of Resistant Obsessive Compulsive Disorder: A Randomized Controlled Trial
Phase 1
- Conditions
- Obsessive Compulsive Disorder.Obsessive-compulsive disorder
- Registration Number
- IRCT20230526058298N1
- Lead Sponsor
- Postgraduate Medical Institute Lahore
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
?Patients of age 16-65 years of either gender
?Patients diagnosed with obsessive compulsive disorder (as per operational definition) with Y-BOCS score =16.
Exclusion Criteria
?Pregnant females
?Patient allergic to trial drugs
?Patient having an organic cause for their symptoms
?Patient with comorbid conditions that aggravate the condition or develop depression and anxiety
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method YALE-BROWN OBSESSIVE COMPULSIVE SCALE. Timepoint: 3 months. Method of measurement: scoring system.
- Secondary Outcome Measures
Name Time Method